Pregnancy News and Research RSS Feed - Pregnancy News and Research Twitter

Systematic review shows hepatitis B and C testing lacking in many European countries

Systematic review shows hepatitis B and C testing lacking in many European countries

The apparent dearth of research on hepatitis B and C testing in many European countries could be hampering efforts to identify infected individuals, according to results from a comprehensive review of 136 studies presented today at The International Liver Congress 2015. [More]
New pregnancy app for Apple Watch now available from The Bump

New pregnancy app for Apple Watch now available from The Bump

The Bump, a leading multiplatform pregnancy and parenting brand, today announced the launch of The Bump Pregnancy App for Apple Watch. The pregnancy app is a complement to the brand's mobile iOS app and offers a customized user experience, serving only the most relevant content and tools to match the user's week of pregnancy. [More]
Text messaging service effective for delivering sexual health information to at-risk teens

Text messaging service effective for delivering sexual health information to at-risk teens

Text messaging that connects teens with sexual health educators is effective for delivering sexual health information, according to a recent study in The Edward R. Murrow College of Communication at Washington State University. The research abstract is online and the work will appear in an upcoming print issue of the journal Health Education and Behavior. [More]
Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Research highlights value of serological testing for Coeliac disease in anyone with symptoms

Coeliac disease is one of the most common life-long conditions in Europe, yet many people remain undiagnosed and lengthy diagnostic delays may be putting lives at risk. Today, doctors are being urged to consider testing for Coeliac disease in anyone showing signs and symptoms of the condition and to consider screening everyone in high-risk groups. [More]
Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Positive CHMP opinion recommends RELISTOR for treatment of opioid-induced constipation

Valeant Pharmaceuticals International, Inc. and Progenics Pharmaceuticals, Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending a new indication for RELISTOR (methylnaltrexone bromide) Subcutaneous Injection for the treatment of opioid-induced constipation (OIC) when response to laxative therapy has not been sufficient in adult patients, aged 18 years and older. [More]
Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, LifeLabs sign new agreement for non-invasive prenatal testing in Canada

Natera, Inc., a global leader in non-invasive genetic testing, and LifeLabs Medical Laboratory Services today announced a new agreement that gives LifeLabs the rights to perform non-invasive prenatal testing (NIPT) in Canada using Natera technology. [More]
Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Lilly receives fourth FDA approval for CYRAMZA (ramucirumab)

Eli Lilly and Company has received its fourth U.S. Food and Drug Administration approval for CYRAMZA (ramucirumab). CYRAMZA (ramucirumab injection 10 mg/mL solution) is now also indicated in combination with FOLFIRI (irinotecan, folinic acid, and 5-fluorouracil) chemotherapy for the treatment of patients with metastatic colorectal cancer (mCRC) with disease progression on or after prior therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine. [More]
Alternative treatment options for uterine fibroids

Alternative treatment options for uterine fibroids

A 47-year-old African-American woman has heavy menstrual bleeding and iron-deficiency anemia. She reports the frequent need to urinate during the night and throughout the day. A colonoscopy is negative and an ultrasonography shows a modestly enlarged uterus with three uterine fibroids, noncancerous growths of the uterus. [More]
Actor Stephen McGann explains how issues of medical accuracy were addressed in Call the Midwife drama

Actor Stephen McGann explains how issues of medical accuracy were addressed in Call the Midwife drama

Actor Stephen McGann, who plays GP Dr Patrick Turner in the hit BBC period drama Call the Midwife, has described the steps taken by the writers, production team and actors to ensure the series has sufficient medical accuracy and authenticity. In an essay published today by the Journal of the Royal Society of Medicine, McGann writes of the unique insight that the role of Dr Turner has given him into questions regarding the way popular culture portrays medics and medicine. [More]
NUH develops new treatment guidelines to support women suffering from Hyperemesis

NUH develops new treatment guidelines to support women suffering from Hyperemesis

Nottingham’s hospitals (NUH) is the first Trust in the country to develop a new treatment plan to support women suffering from severe sickness during pregnancy. [More]
WHO calls on global health community to address significant gaps in prevention, treatment of malaria

WHO calls on global health community to address significant gaps in prevention, treatment of malaria

WHO is calling on the global health community to urgently address significant gaps in the prevention, diagnosis and treatment of malaria. Despite dramatic declines in malaria cases and deaths since 2000, more than half a million lives are still lost to this preventable disease each year. [More]
Epigenetic processes influence children's later ability to learn and cognitive performance

Epigenetic processes influence children's later ability to learn and cognitive performance

Although it is now widely recognised that a poor start to life has long-term effects on a child's later ability to learn, the mechanisms by which the environment in early life affects later life chances are poorly understood. [More]
Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith presents favorable data from PREVAIL OLE study of Qudexy XR capsules

Upsher-Smith Laboratories, Inc. presented data from a 52-week, open-label extension study (PREVAIL OLE) showing that Qudexy XR (topiramate) extended-release capsules offered a long-term adjunctive treatment option with a favorable tolerability profile for a high proportion of patients with refractory partial-onset seizures (POS). [More]
Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Montefiore and Einstein researchers to present new findings on neurological disorders at AAN 2015

Researchers from Montefiore Health System and Albert Einstein College of Medicine will present new findings on how to effectively treat migraine, and forecast the onset of pain in a number of neurological conditions including dementia in older adults. [More]
Prenatal antidepressant exposure increases anxiety symptoms

Prenatal antidepressant exposure increases anxiety symptoms

Three-year-old siblings exposed to antidepressants in pregnancy show increased anxiety symptoms compared to their unexposed siblings. [More]
Extreme morning sickness during pregnancy linked to developmental problems in children

Extreme morning sickness during pregnancy linked to developmental problems in children

Women who experience extreme morning sickness during pregnancy are three times more likely to have children with developmental issues, including attention disorders and language and speech delays, than woman who have normal nausea and vomiting, a UCLA study has found. [More]
UCLA-led stroke study selected as one of 10 most outstanding research papers by CRF

UCLA-led stroke study selected as one of 10 most outstanding research papers by CRF

A UCLA-led study on improving stroke care was selected by the Clinical Research Forum (CRF) as one of the 10 most outstanding research papers written by teams from across the nation in 2014. The organization highlighted the papers at its fourth annual awards ceremony in Washington, D.C. on April 16. [More]
Global changes in cancer cells' epigenome may determine disease progression

Global changes in cancer cells' epigenome may determine disease progression

Genomic studies have illuminated the ways in which malfunctioning genes can drive cancer growth while stunting the therapeutic effects of chemotherapy and other treatments. But new findings from Weill Cornell Medical College investigators indicate that these genes are only partly to blame for why treatment that was at one point effective ultimately fails for about 40 percent of patients diagnosed with the most common form of non-Hodgkin Lymphoma. [More]
Different pediatric research topics be presented at PAS annual meeting

Different pediatric research topics be presented at PAS annual meeting

Research on electronic cigarettes, teen texting and driving, bullying, mobile device use, health care of immigrant children and other pediatric topics will be presented April 25-28 at the Pediatric Academic Societies annual meeting at the San Diego Convention Center. [More]
Ibrutinib (IMBRUVICA) may be effective for pancreatic ductal adenocarcinoma

Ibrutinib (IMBRUVICA) may be effective for pancreatic ductal adenocarcinoma

Ibrutinib (IMBRUVICA) data presented yesterday by Pharmacyclics, Inc. at the American Association for Cancer Research Annual Meeting suggest that ibrutinib may be an effective therapeutic option for pancreatic ductal adenocarcinoma (PDAC), as shown in both a transgenic mouse model and an in-vivo model of patient-derived xenograft (PDX) mice (grafts of tissue taken from a pancreatic cancer patient and grafted into a mouse). [More]
Advertisement
Advertisement